James A. Mahoney
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
James A. Mahoney has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Livia Casciola-Rosen
Department of Dermatology, The Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD 21205, U.S.A.
2 shared publicationsAndrew J. McKnight
1 shared publication- Andrew Koff
Memorial Sloan Kettering Cancer Center
1 shared publication Antony Rosen
Department of Medicine, The Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD 21205, U.S.A.
1 shared publication- Antony Rosen
Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
1 shared publication Bongi Ntolosi
1 shared publication
Latest Publications
- Open Access
- 1 February 2002
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 361 (3) , 587-595
The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis
In the present study, we demonstrate that a human homologue of Ufd2p (a yeast protein that catalyses the formation of long polyubiquitin chains, and is implicated in responses to environmental stress), UFD2 (ubiquitin fusion degradation protein-2), is cleaved during apoptosis induced by multiple stimuli, including UVB irradiation, Fas ligation, staurosporine treatment and cytotoxic lymphocyte granule-induced death. Caspase 6 and granzyme B efficiently cleave UFD2 [kcat/Km = (4–5)×104 M−1·s−1] at Asp123, whereas caspases 3 and 7 cleave UFD2 approx. 10-fold less efficiently immediately upstream at Asp109. Thus UFD2 is added to the growing list of proteins with closely spaced caspase and granzyme B cleavage sites, suggesting the presence of a previously unrecognized, conserved motif. Both cleavage sites are contained and conserved within a novel 300-amino-acid N-terminal domain present in apparent UFD2 orthologues in mice and zebrafish, but absent in all UFD2 family members in lower eukaryotes. Full-length recombinant UFD2 exhibited ubiquitin—protein ligase ('E3')-like ubiquitination activity in vitro, but this activity was abolished in recombinant UFD2 truncated at the granzyme B/caspase 6 cleavage site. Cleavage of UFD2 by caspases or granzyme B within this putative regulatory N-terminal domain might have important functional consequences within the apoptotic cascade.
- 1 February 2002
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 361 (3) , 587-595
Open AccessThe human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis
In the present study, we demonstrate that a human homologue of Ufd2p (a yeast protein that catalyses the formation of long polyubiquitin chains, and is implicated in responses to environmental stress), UFD2 (ubiquitin fusion degradation protein-2), is cleaved during apoptosis induced by multiple stimuli, including UVB irradiation, Fas ligation, staurosporine treatment and cytotoxic lymphocyte granule-induced death. Caspase 6 and granzyme B efficiently cleave UFD2 [kcat/Km = (4–5)×104 M−1·s−1] at Asp123, whereas caspases 3 and 7 cleave UFD2 approx. 10-fold less efficiently immediately upstream at Asp109. Thus UFD2 is added to the growing list of proteins with closely spaced caspase and granzyme B cleavage sites, suggesting the presence of a previously unrecognized, conserved motif. Both cleavage sites are contained and conserved within a novel 300-amino-acid N-terminal domain present in apparent UFD2 orthologues in mice and zebrafish, but absent in all UFD2 family members in lower eukaryotes. Full-length recombinant UFD2 exhibited ubiquitin—protein ligase ('E3')-like ubiquitination activity in vitro, but this activity was abolished in recombinant UFD2 truncated at the granzyme B/caspase 6 cleavage site. Cleavage of UFD2 by caspases or granzyme B within this putative regulatory N-terminal domain might have important functional consequences within the apoptotic cascade.
- 30 April 2000
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , A961
Expression cloning of a novel autoantigen and caspase substrate: Human ubiquitin fusion degradation protein-2 (UFD2)
- 30 April 2000
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , A961
Expression cloning of a novel autoantigen and caspase substrate: Human ubiquitin fusion degradation protein-2 (UFD2)